Purpose

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Functional or degenerative TR moderate or greater - Symptomatic despite medical therapy - The Local Site Heart Team determines that the patient is appropriate for transcatheter tricuspid valve replacement

Exclusion Criteria

  • Unsuitable anatomy - Previous tricuspid valve repair or replacement - Comorbid condition(s) that, in the opinion of the investigator, could limit the patient's ability to participate in the study, including compliance with follow- up requirements, or that could impact the scientific integrity of the study.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Treatment
Treatment with the Edwards EVOQUE Tricuspid Transcatheter Valve Replacement System
  • Device: Transcatheter Tricuspid Valve Replacement
    Replacement of the tricuspid valve through a transcatheter approach
    Other names:
    • Edwards EVOQUE Tricuspid Valve Replacement System

Recruiting Locations

Massachusetts General Hospital Boston
Boston, Massachusetts 02114
Contact:
Lina Fu
617-643-1371
lfu2@partners.org

More Details

Status
Recruiting
Sponsor
Edwards Lifesciences

Study Contact

TMTT Clinical
949-250-2500
TMTT_Clinical@Edwards.com

Detailed Description

The study is a multi-center, prospective, single arm study designed to evaluate the safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.